nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—Azacitidine—Gemcitabine—urinary bladder cancer	0.404	1	CrCrCtD
Adenosine triphosphate—ABCB1—Mitomycin—urinary bladder cancer	0.0371	0.177	CbGbCtD
Adenosine triphosphate—ABCB11—Doxorubicin—urinary bladder cancer	0.0303	0.144	CbGbCtD
Adenosine triphosphate—ABCC2—Carboplatin—urinary bladder cancer	0.0278	0.133	CbGbCtD
Adenosine triphosphate—ABCC2—Cisplatin—urinary bladder cancer	0.0238	0.113	CbGbCtD
Adenosine triphosphate—ABCC2—Etoposide—urinary bladder cancer	0.0234	0.111	CbGbCtD
Adenosine triphosphate—ABCC2—Doxorubicin—urinary bladder cancer	0.0159	0.0759	CbGbCtD
Adenosine triphosphate—ABCC2—Methotrexate—urinary bladder cancer	0.0154	0.0735	CbGbCtD
Adenosine triphosphate—ABCB1—Gemcitabine—urinary bladder cancer	0.0107	0.0508	CbGbCtD
Adenosine triphosphate—ABCB1—Cisplatin—urinary bladder cancer	0.00775	0.0369	CbGbCtD
Adenosine triphosphate—ABCB1—Etoposide—urinary bladder cancer	0.00762	0.0363	CbGbCtD
Adenosine triphosphate—ABCB1—Doxorubicin—urinary bladder cancer	0.0052	0.0247	CbGbCtD
Adenosine triphosphate—ABCB1—Methotrexate—urinary bladder cancer	0.00503	0.024	CbGbCtD
Adenosine triphosphate—AKT1—penis—urinary bladder cancer	0.0043	0.0252	CbGeAlD
Adenosine triphosphate—CDK15—prostate gland—urinary bladder cancer	0.00337	0.0198	CbGeAlD
Adenosine triphosphate—ABCC8—penis—urinary bladder cancer	0.00303	0.0178	CbGeAlD
Adenosine triphosphate—APAF1—prostate gland—urinary bladder cancer	0.003	0.0176	CbGeAlD
Adenosine triphosphate—Flavin adenine dinucleotide—POR—urinary bladder cancer	0.00219	0.51	CrCbGaD
Adenosine triphosphate—ADRBK2—prostate gland—urinary bladder cancer	0.00211	0.0124	CbGeAlD
Adenosine triphosphate—ABCG1—prostate gland—urinary bladder cancer	0.00191	0.0112	CbGeAlD
Adenosine triphosphate—ACVRL1—prostate gland—urinary bladder cancer	0.00191	0.0112	CbGeAlD
Adenosine triphosphate—CDK15—female reproductive system—urinary bladder cancer	0.00184	0.0108	CbGeAlD
Adenosine triphosphate—ABCC9—prostate gland—urinary bladder cancer	0.00182	0.0107	CbGeAlD
Adenosine triphosphate—HSPA1A—prostate gland—urinary bladder cancer	0.00179	0.0105	CbGeAlD
Adenosine triphosphate—HSPA1B—prostate gland—urinary bladder cancer	0.00179	0.0105	CbGeAlD
Adenosine triphosphate—AMHR2—female reproductive system—urinary bladder cancer	0.0017	0.00996	CbGeAlD
Adenosine triphosphate—ARAF—prostate gland—urinary bladder cancer	0.00167	0.00981	CbGeAlD
Adenosine triphosphate—ACVR1B—prostate gland—urinary bladder cancer	0.00162	0.00952	CbGeAlD
Adenosine triphosphate—ABCG1—seminal vesicle—urinary bladder cancer	0.00162	0.0095	CbGeAlD
Adenosine triphosphate—ACVRL1—seminal vesicle—urinary bladder cancer	0.00162	0.0095	CbGeAlD
Adenosine triphosphate—ASNA1—prostate gland—urinary bladder cancer	0.00157	0.0092	CbGeAlD
Adenosine triphosphate—AFG3L2—prostate gland—urinary bladder cancer	0.00155	0.00908	CbGeAlD
Adenosine triphosphate—HSPA1B—seminal vesicle—urinary bladder cancer	0.00151	0.00887	CbGeAlD
Adenosine triphosphate—HSPA1A—seminal vesicle—urinary bladder cancer	0.00151	0.00887	CbGeAlD
Adenosine triphosphate—NAE1—prostate gland—urinary bladder cancer	0.00151	0.00886	CbGeAlD
Adenosine triphosphate—ARAF—seminal vesicle—urinary bladder cancer	0.00141	0.00829	CbGeAlD
Adenosine triphosphate—ACVRL1—epithelium—urinary bladder cancer	0.00141	0.00826	CbGeAlD
Adenosine triphosphate—SLC25A4—prostate gland—urinary bladder cancer	0.00141	0.00825	CbGeAlD
Adenosine triphosphate—TNK2—prostate gland—urinary bladder cancer	0.00138	0.00809	CbGeAlD
Adenosine triphosphate—ACVRL1—smooth muscle tissue—urinary bladder cancer	0.00136	0.00796	CbGeAlD
Adenosine triphosphate—ASNA1—seminal vesicle—urinary bladder cancer	0.00133	0.00778	CbGeAlD
Adenosine triphosphate—AFG3L2—seminal vesicle—urinary bladder cancer	0.00131	0.00768	CbGeAlD
Adenosine triphosphate—ABCC9—smooth muscle tissue—urinary bladder cancer	0.00129	0.00756	CbGeAlD
Adenosine triphosphate—ACVRL1—urethra—urinary bladder cancer	0.00128	0.00752	CbGeAlD
Adenosine triphosphate—ABCG1—urethra—urinary bladder cancer	0.00128	0.00752	CbGeAlD
Adenosine triphosphate—NAE1—seminal vesicle—urinary bladder cancer	0.00128	0.00749	CbGeAlD
Adenosine triphosphate—HSPA1A—smooth muscle tissue—urinary bladder cancer	0.00126	0.00742	CbGeAlD
Adenosine triphosphate—Flavin adenine dinucleotide—NQO1—urinary bladder cancer	0.00126	0.293	CrCbGaD
Adenosine triphosphate—ADRBK1—prostate gland—urinary bladder cancer	0.00125	0.00732	CbGeAlD
Adenosine triphosphate—ACSS1—prostate gland—urinary bladder cancer	0.00125	0.00732	CbGeAlD
Adenosine triphosphate—ABCA1—prostate gland—urinary bladder cancer	0.00123	0.00724	CbGeAlD
Adenosine triphosphate—NT5C2—prostate gland—urinary bladder cancer	0.00122	0.00716	CbGeAlD
Adenosine triphosphate—ACVR1—prostate gland—urinary bladder cancer	0.00122	0.00716	CbGeAlD
Adenosine triphosphate—HSPA1B—urethra—urinary bladder cancer	0.0012	0.00702	CbGeAlD
Adenosine triphosphate—HSPA1A—urethra—urinary bladder cancer	0.0012	0.00702	CbGeAlD
Adenosine triphosphate—ACSS2—prostate gland—urinary bladder cancer	0.0012	0.00702	CbGeAlD
Adenosine triphosphate—ACSL1—prostate gland—urinary bladder cancer	0.00119	0.00697	CbGeAlD
Adenosine triphosphate—ABL2—prostate gland—urinary bladder cancer	0.00117	0.00684	CbGeAlD
Adenosine triphosphate—ADRBK2—female reproductive system—urinary bladder cancer	0.00115	0.00676	CbGeAlD
Adenosine triphosphate—ARAF—renal system—urinary bladder cancer	0.00114	0.00668	CbGeAlD
Adenosine triphosphate—PRKAA1—prostate gland—urinary bladder cancer	0.00112	0.0066	CbGeAlD
Adenosine triphosphate—ARAF—urethra—urinary bladder cancer	0.00112	0.00657	CbGeAlD
Adenosine triphosphate—ASNA1—smooth muscle tissue—urinary bladder cancer	0.00111	0.00651	CbGeAlD
Adenosine triphosphate—ACVR1B—renal system—urinary bladder cancer	0.00111	0.00649	CbGeAlD
Adenosine triphosphate—NAE1—smooth muscle tissue—urinary bladder cancer	0.00107	0.00627	CbGeAlD
Adenosine triphosphate—ASNA1—renal system—urinary bladder cancer	0.00107	0.00627	CbGeAlD
Adenosine triphosphate—ACSS1—seminal vesicle—urinary bladder cancer	0.00105	0.00619	CbGeAlD
Adenosine triphosphate—AFG3L2—renal system—urinary bladder cancer	0.00105	0.00619	CbGeAlD
Adenosine triphosphate—ASNA1—urethra—urinary bladder cancer	0.00105	0.00616	CbGeAlD
Adenosine triphosphate—ACVRL1—female reproductive system—urinary bladder cancer	0.00104	0.00613	CbGeAlD
Adenosine triphosphate—ADRBK2—vagina—urinary bladder cancer	0.00104	0.00612	CbGeAlD
Adenosine triphosphate—AFG3L2—urethra—urinary bladder cancer	0.00104	0.00608	CbGeAlD
Adenosine triphosphate—NT5C2—seminal vesicle—urinary bladder cancer	0.00103	0.00606	CbGeAlD
Adenosine triphosphate—ACVR1—seminal vesicle—urinary bladder cancer	0.00103	0.00606	CbGeAlD
Adenosine triphosphate—NAE1—renal system—urinary bladder cancer	0.00103	0.00604	CbGeAlD
Adenosine triphosphate—AKT1—prostate gland—urinary bladder cancer	0.00103	0.00602	CbGeAlD
Adenosine triphosphate—ASNS—prostate gland—urinary bladder cancer	0.00103	0.00602	CbGeAlD
Adenosine triphosphate—ACSS2—seminal vesicle—urinary bladder cancer	0.00101	0.00594	CbGeAlD
Adenosine triphosphate—NAE1—urethra—urinary bladder cancer	0.00101	0.00593	CbGeAlD
Adenosine triphosphate—ACSL1—seminal vesicle—urinary bladder cancer	0.001	0.0059	CbGeAlD
Adenosine triphosphate—AMHR2—lymph node—urinary bladder cancer	0.000993	0.00583	CbGeAlD
Adenosine triphosphate—APAF1—lymph node—urinary bladder cancer	0.000959	0.00563	CbGeAlD
Adenosine triphosphate—SLC25A4—renal system—urinary bladder cancer	0.000959	0.00563	CbGeAlD
Adenosine triphosphate—ABCG1—vagina—urinary bladder cancer	0.000945	0.00555	CbGeAlD
Adenosine triphosphate—ACVRL1—vagina—urinary bladder cancer	0.000945	0.00555	CbGeAlD
Adenosine triphosphate—ARAF—female reproductive system—urinary bladder cancer	0.000912	0.00535	CbGeAlD
Adenosine triphosphate—ASS1—prostate gland—urinary bladder cancer	0.000894	0.00525	CbGeAlD
Adenosine triphosphate—ACVR1B—female reproductive system—urinary bladder cancer	0.000885	0.0052	CbGeAlD
Adenosine triphosphate—ADRBK1—smooth muscle tissue—urinary bladder cancer	0.000883	0.00518	CbGeAlD
Adenosine triphosphate—HSPA1A—vagina—urinary bladder cancer	0.000882	0.00518	CbGeAlD
Adenosine triphosphate—HSPA1B—vagina—urinary bladder cancer	0.000882	0.00518	CbGeAlD
Adenosine triphosphate—ASNS—seminal vesicle—urinary bladder cancer	0.000868	0.00509	CbGeAlD
Adenosine triphosphate—AKT1—seminal vesicle—urinary bladder cancer	0.000868	0.00509	CbGeAlD
Adenosine triphosphate—NT5C2—smooth muscle tissue—urinary bladder cancer	0.000864	0.00507	CbGeAlD
Adenosine triphosphate—ASNA1—female reproductive system—urinary bladder cancer	0.000856	0.00502	CbGeAlD
Adenosine triphosphate—ACSS1—renal system—urinary bladder cancer	0.00085	0.00499	CbGeAlD
Adenosine triphosphate—ADRBK1—renal system—urinary bladder cancer	0.00085	0.00499	CbGeAlD
Adenosine triphosphate—Adenosine monophosphate—SRC—urinary bladder cancer	0.000846	0.197	CrCbGaD
Adenosine triphosphate—AFG3L2—female reproductive system—urinary bladder cancer	0.000845	0.00496	CbGeAlD
Adenosine triphosphate—ABCA1—renal system—urinary bladder cancer	0.000841	0.00494	CbGeAlD
Adenosine triphosphate—ACSS1—urethra—urinary bladder cancer	0.000835	0.0049	CbGeAlD
Adenosine triphosphate—NT5C2—renal system—urinary bladder cancer	0.000832	0.00488	CbGeAlD
Adenosine triphosphate—ACVR1—renal system—urinary bladder cancer	0.000832	0.00488	CbGeAlD
Adenosine triphosphate—ARAF—vagina—urinary bladder cancer	0.000825	0.00484	CbGeAlD
Adenosine triphosphate—NAE1—female reproductive system—urinary bladder cancer	0.000824	0.00484	CbGeAlD
Adenosine triphosphate—ACVR1—urethra—urinary bladder cancer	0.000817	0.0048	CbGeAlD
Adenosine triphosphate—NT5C2—urethra—urinary bladder cancer	0.000817	0.0048	CbGeAlD
Adenosine triphosphate—ACSS2—renal system—urinary bladder cancer	0.000815	0.00478	CbGeAlD
Adenosine triphosphate—ACSL1—renal system—urinary bladder cancer	0.00081	0.00475	CbGeAlD
Adenosine triphosphate—ACSS2—urethra—urinary bladder cancer	0.000801	0.0047	CbGeAlD
Adenosine triphosphate—ACSL1—urethra—urinary bladder cancer	0.000795	0.00467	CbGeAlD
Adenosine triphosphate—ALK—female reproductive system—urinary bladder cancer	0.000784	0.0046	CbGeAlD
Adenosine triphosphate—ADK—prostate gland—urinary bladder cancer	0.000781	0.00458	CbGeAlD
Adenosine triphosphate—ASNA1—vagina—urinary bladder cancer	0.000774	0.00454	CbGeAlD
Adenosine triphosphate—SLC25A4—female reproductive system—urinary bladder cancer	0.000768	0.00451	CbGeAlD
Adenosine triphosphate—PRKAA1—renal system—urinary bladder cancer	0.000766	0.0045	CbGeAlD
Adenosine triphosphate—AFG3L2—vagina—urinary bladder cancer	0.000764	0.00448	CbGeAlD
Adenosine triphosphate—ASS1—seminal vesicle—urinary bladder cancer	0.000756	0.00444	CbGeAlD
Adenosine triphosphate—AKT1—epithelium—urinary bladder cancer	0.000754	0.00442	CbGeAlD
Adenosine triphosphate—TNK2—female reproductive system—urinary bladder cancer	0.000753	0.00442	CbGeAlD
Adenosine triphosphate—NAE1—vagina—urinary bladder cancer	0.000745	0.00437	CbGeAlD
Adenosine triphosphate—AKT1—smooth muscle tissue—urinary bladder cancer	0.000726	0.00426	CbGeAlD
Adenosine triphosphate—ASNS—smooth muscle tissue—urinary bladder cancer	0.000726	0.00426	CbGeAlD
Adenosine triphosphate—ABCC8—prostate gland—urinary bladder cancer	0.000724	0.00425	CbGeAlD
Adenosine triphosphate—AKT1—renal system—urinary bladder cancer	0.000699	0.0041	CbGeAlD
Adenosine triphosphate—SLC25A4—vagina—urinary bladder cancer	0.000694	0.00407	CbGeAlD
Adenosine triphosphate—AKT1—urethra—urinary bladder cancer	0.000687	0.00403	CbGeAlD
Adenosine triphosphate—ASNS—urethra—urinary bladder cancer	0.000687	0.00403	CbGeAlD
Adenosine triphosphate—ADRBK1—female reproductive system—urinary bladder cancer	0.000681	0.004	CbGeAlD
Adenosine triphosphate—ACSS1—female reproductive system—urinary bladder cancer	0.000681	0.004	CbGeAlD
Adenosine triphosphate—ADRBK2—lymph node—urinary bladder cancer	0.000674	0.00396	CbGeAlD
Adenosine triphosphate—ABCA1—female reproductive system—urinary bladder cancer	0.000673	0.00395	CbGeAlD
Adenosine triphosphate—NT5C2—female reproductive system—urinary bladder cancer	0.000666	0.00391	CbGeAlD
Adenosine triphosphate—ACVR1—female reproductive system—urinary bladder cancer	0.000666	0.00391	CbGeAlD
Adenosine triphosphate—HSPA1A—Zalcitabine—Gemcitabine—urinary bladder cancer	0.000664	0.118	CbGdCrCtD
Adenosine triphosphate—ADK—seminal vesicle—urinary bladder cancer	0.000661	0.00388	CbGeAlD
Adenosine triphosphate—ASS1—epithelium—urinary bladder cancer	0.000657	0.00386	CbGeAlD
Adenosine triphosphate—ACSS2—female reproductive system—urinary bladder cancer	0.000653	0.00383	CbGeAlD
Adenosine triphosphate—ACSL1—female reproductive system—urinary bladder cancer	0.000648	0.00381	CbGeAlD
Adenosine triphosphate—ASS1—smooth muscle tissue—urinary bladder cancer	0.000633	0.00372	CbGeAlD
Adenosine triphosphate—ACSS1—vagina—urinary bladder cancer	0.000616	0.00361	CbGeAlD
Adenosine triphosphate—ADRBK1—vagina—urinary bladder cancer	0.000616	0.00361	CbGeAlD
Adenosine triphosphate—PRKAA1—female reproductive system—urinary bladder cancer	0.000614	0.0036	CbGeAlD
Adenosine triphosphate—ABCC8—seminal vesicle—urinary bladder cancer	0.000613	0.0036	CbGeAlD
Adenosine triphosphate—ACVRL1—lymph node—urinary bladder cancer	0.000611	0.00359	CbGeAlD
Adenosine triphosphate—ABCG1—lymph node—urinary bladder cancer	0.000611	0.00359	CbGeAlD
Adenosine triphosphate—ASS1—renal system—urinary bladder cancer	0.00061	0.00358	CbGeAlD
Adenosine triphosphate—ABCA1—vagina—urinary bladder cancer	0.000609	0.00357	CbGeAlD
Adenosine triphosphate—NT5C2—vagina—urinary bladder cancer	0.000603	0.00354	CbGeAlD
Adenosine triphosphate—ACVR1—vagina—urinary bladder cancer	0.000603	0.00354	CbGeAlD
Adenosine triphosphate—ASS1—urethra—urinary bladder cancer	0.000599	0.00351	CbGeAlD
Adenosine triphosphate—ADCY1—lymph node—urinary bladder cancer	0.000593	0.00348	CbGeAlD
Adenosine triphosphate—ACSS2—vagina—urinary bladder cancer	0.00059	0.00346	CbGeAlD
Adenosine triphosphate—ACSL1—vagina—urinary bladder cancer	0.000586	0.00344	CbGeAlD
Adenosine triphosphate—ABCC9—lymph node—urinary bladder cancer	0.000581	0.00341	CbGeAlD
Adenosine triphosphate—ABL2—vagina—urinary bladder cancer	0.000575	0.00338	CbGeAlD
Adenosine triphosphate—HSPA1B—lymph node—urinary bladder cancer	0.00057	0.00335	CbGeAlD
Adenosine triphosphate—HSPA1A—lymph node—urinary bladder cancer	0.00057	0.00335	CbGeAlD
Adenosine triphosphate—ABL1—prostate gland—urinary bladder cancer	0.000562	0.0033	CbGeAlD
Adenosine triphosphate—AKT1—female reproductive system—urinary bladder cancer	0.00056	0.00329	CbGeAlD
Adenosine triphosphate—ADK—smooth muscle tissue—urinary bladder cancer	0.000553	0.00325	CbGeAlD
Adenosine triphosphate—ARAF—lymph node—urinary bladder cancer	0.000534	0.00313	CbGeAlD
Adenosine triphosphate—ADK—renal system—urinary bladder cancer	0.000532	0.00312	CbGeAlD
Adenosine triphosphate—ADK—urethra—urinary bladder cancer	0.000523	0.00307	CbGeAlD
Adenosine triphosphate—HSPA1A—Idarubicin—Valrubicin—urinary bladder cancer	0.000519	0.0926	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Valrubicin—urinary bladder cancer	0.000519	0.0926	CbGdCrCtD
Adenosine triphosphate—ACVR1B—lymph node—urinary bladder cancer	0.000518	0.00304	CbGeAlD
Adenosine triphosphate—ABCC8—smooth muscle tissue—urinary bladder cancer	0.000513	0.00301	CbGeAlD
Adenosine triphosphate—AKT1—vagina—urinary bladder cancer	0.000506	0.00297	CbGeAlD
Adenosine triphosphate—ASNS—vagina—urinary bladder cancer	0.000506	0.00297	CbGeAlD
Adenosine triphosphate—ASNA1—lymph node—urinary bladder cancer	0.000501	0.00294	CbGeAlD
Adenosine triphosphate—AFG3L2—lymph node—urinary bladder cancer	0.000494	0.0029	CbGeAlD
Adenosine triphosphate—ABCC8—renal system—urinary bladder cancer	0.000494	0.0029	CbGeAlD
Adenosine triphosphate—ASS1—female reproductive system—urinary bladder cancer	0.000488	0.00287	CbGeAlD
Adenosine triphosphate—ABCC2—prostate gland—urinary bladder cancer	0.000486	0.00285	CbGeAlD
Adenosine triphosphate—NAE1—lymph node—urinary bladder cancer	0.000482	0.00283	CbGeAlD
Adenosine triphosphate—ABL1—seminal vesicle—urinary bladder cancer	0.000475	0.00279	CbGeAlD
Adenosine triphosphate—ALK—lymph node—urinary bladder cancer	0.000458	0.00269	CbGeAlD
Adenosine triphosphate—SLC25A4—lymph node—urinary bladder cancer	0.000449	0.00264	CbGeAlD
Adenosine triphosphate—ASS1—vagina—urinary bladder cancer	0.000442	0.00259	CbGeAlD
Adenosine triphosphate—TNK2—lymph node—urinary bladder cancer	0.00044	0.00258	CbGeAlD
Adenosine triphosphate—ADK—female reproductive system—urinary bladder cancer	0.000426	0.0025	CbGeAlD
Adenosine triphosphate—ADRBK1—lymph node—urinary bladder cancer	0.000398	0.00234	CbGeAlD
Adenosine triphosphate—ACSS1—lymph node—urinary bladder cancer	0.000398	0.00234	CbGeAlD
Adenosine triphosphate—ABL1—smooth muscle tissue—urinary bladder cancer	0.000398	0.00234	CbGeAlD
Adenosine triphosphate—ABCA1—lymph node—urinary bladder cancer	0.000394	0.00231	CbGeAlD
Adenosine triphosphate—ABL1—Epirubicin—Valrubicin—urinary bladder cancer	0.000393	0.0702	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Valrubicin—urinary bladder cancer	0.000393	0.0702	CbGdCrCtD
Adenosine triphosphate—ABL1—Doxorubicin—Valrubicin—urinary bladder cancer	0.000393	0.0702	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Valrubicin—urinary bladder cancer	0.000393	0.0702	CbGdCrCtD
Adenosine triphosphate—ACVR1—lymph node—urinary bladder cancer	0.00039	0.00229	CbGeAlD
Adenosine triphosphate—NT5C2—lymph node—urinary bladder cancer	0.00039	0.00229	CbGeAlD
Adenosine triphosphate—ADK—vagina—urinary bladder cancer	0.000386	0.00226	CbGeAlD
Adenosine triphosphate—ABL1—renal system—urinary bladder cancer	0.000383	0.00225	CbGeAlD
Adenosine triphosphate—ACSS2—lymph node—urinary bladder cancer	0.000382	0.00224	CbGeAlD
Adenosine triphosphate—ACSL1—lymph node—urinary bladder cancer	0.000379	0.00223	CbGeAlD
Adenosine triphosphate—ABL1—urethra—urinary bladder cancer	0.000376	0.00221	CbGeAlD
Adenosine triphosphate—ABL2—lymph node—urinary bladder cancer	0.000372	0.00218	CbGeAlD
Adenosine triphosphate—PRKAA1—lymph node—urinary bladder cancer	0.000359	0.00211	CbGeAlD
Adenosine triphosphate—HSPA1A—Podofilox—Etoposide—urinary bladder cancer	0.000346	0.0618	CbGdCrCtD
Adenosine triphosphate—ABCC2—renal system—urinary bladder cancer	0.000331	0.00194	CbGeAlD
Adenosine triphosphate—ASNS—lymph node—urinary bladder cancer	0.000328	0.00192	CbGeAlD
Adenosine triphosphate—AKT1—lymph node—urinary bladder cancer	0.000328	0.00192	CbGeAlD
Adenosine triphosphate—ABL1—female reproductive system—urinary bladder cancer	0.000307	0.0018	CbGeAlD
Adenosine triphosphate—ASS1—lymph node—urinary bladder cancer	0.000286	0.00168	CbGeAlD
Adenosine triphosphate—ABL1—vagina—urinary bladder cancer	0.000278	0.00163	CbGeAlD
Adenosine triphosphate—ABCC2—female reproductive system—urinary bladder cancer	0.000265	0.00156	CbGeAlD
Adenosine triphosphate—ADK—lymph node—urinary bladder cancer	0.000249	0.00146	CbGeAlD
Adenosine triphosphate—HSPA1A—Cytarabine—Gemcitabine—urinary bladder cancer	0.000195	0.0347	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Epirubicin—urinary bladder cancer	0.000181	0.0322	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Idarubicin—Epirubicin—urinary bladder cancer	0.000181	0.0322	CbGdCrCtD
Adenosine triphosphate—ABL1—lymph node—urinary bladder cancer	0.000179	0.00105	CbGeAlD
Adenosine triphosphate—ABCB1—prostate gland—urinary bladder cancer	0.000175	0.00103	CbGeAlD
Adenosine triphosphate—HSPA1A—Idarubicin—Doxorubicin—urinary bladder cancer	0.000167	0.0298	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Doxorubicin—urinary bladder cancer	0.000167	0.0298	CbGdCrCtD
Adenosine triphosphate—AKT1—Azacitidine—Gemcitabine—urinary bladder cancer	0.000164	0.0293	CbGdCrCtD
Adenosine triphosphate—ABCC2—lymph node—urinary bladder cancer	0.000155	0.000911	CbGeAlD
Adenosine triphosphate—ABCB1—seminal vesicle—urinary bladder cancer	0.000148	0.000868	CbGeAlD
Adenosine triphosphate—HSPA1A—Azacitidine—Gemcitabine—urinary bladder cancer	0.00014	0.0249	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Epirubicin—urinary bladder cancer	0.000137	0.0244	CbGdCrCtD
Adenosine triphosphate—ABL1—Doxorubicin—Epirubicin—urinary bladder cancer	0.000137	0.0244	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Epirubicin—urinary bladder cancer	0.000137	0.0244	CbGdCrCtD
Adenosine triphosphate—ABCB1—epithelium—urinary bladder cancer	0.000128	0.000754	CbGeAlD
Adenosine triphosphate—ABL1—Daunorubicin—Doxorubicin—urinary bladder cancer	0.000127	0.0226	CbGdCrCtD
Adenosine triphosphate—ABL1—Epirubicin—Doxorubicin—urinary bladder cancer	0.000127	0.0226	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Doxorubicin—urinary bladder cancer	0.000127	0.0226	CbGdCrCtD
Adenosine triphosphate—ABCB1—renal system—urinary bladder cancer	0.000119	0.000699	CbGeAlD
Adenosine triphosphate—ABCB1—urethra—urinary bladder cancer	0.000117	0.000687	CbGeAlD
Adenosine triphosphate—ABCB1—female reproductive system—urinary bladder cancer	9.54e-05	0.00056	CbGeAlD
Adenosine triphosphate—ABCB1—vagina—urinary bladder cancer	8.63e-05	0.000506	CbGeAlD
Adenosine triphosphate—ABCB1—lymph node—urinary bladder cancer	5.58e-05	0.000328	CbGeAlD
Adenosine triphosphate—ABL1—Hemostasis—SRC—urinary bladder cancer	7.86e-06	3.82e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PTGS2—urinary bladder cancer	7.85e-06	3.82e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MTHFR—urinary bladder cancer	7.78e-06	3.78e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—TERT—urinary bladder cancer	7.76e-06	3.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CDKN1A—urinary bladder cancer	7.75e-06	3.77e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—CDKN1A—urinary bladder cancer	7.74e-06	3.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—PTEN—urinary bladder cancer	7.74e-06	3.76e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TP53—urinary bladder cancer	7.73e-06	3.76e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—PTEN—urinary bladder cancer	7.73e-06	3.76e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—FGFR3—urinary bladder cancer	7.71e-06	3.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—EP300—urinary bladder cancer	7.67e-06	3.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—ESR1—urinary bladder cancer	7.66e-06	3.73e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—CDKN1A—urinary bladder cancer	7.65e-06	3.72e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PPARG—urinary bladder cancer	7.64e-06	3.72e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—PTEN—urinary bladder cancer	7.63e-06	3.71e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CREBBP—urinary bladder cancer	7.6e-06	3.7e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.6e-06	3.7e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IGF1—urinary bladder cancer	7.51e-06	3.65e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—SRC—urinary bladder cancer	7.46e-06	3.63e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—TYMS—urinary bladder cancer	7.46e-06	3.63e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—MTHFR—urinary bladder cancer	7.45e-06	3.63e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—ESR1—urinary bladder cancer	7.45e-06	3.62e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CDKN1A—urinary bladder cancer	7.43e-06	3.62e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—PTEN—urinary bladder cancer	7.42e-06	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—EGFR—urinary bladder cancer	7.41e-06	3.6e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—HRAS—urinary bladder cancer	7.39e-06	3.6e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.39e-06	3.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—EP300—urinary bladder cancer	7.38e-06	3.59e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—NCOR1—urinary bladder cancer	7.37e-06	3.59e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—GSTM1—urinary bladder cancer	7.37e-06	3.59e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—CREBBP—urinary bladder cancer	7.34e-06	3.57e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—FGFR3—urinary bladder cancer	7.31e-06	3.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—EP300—urinary bladder cancer	7.27e-06	3.54e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—SRC—urinary bladder cancer	7.17e-06	3.49e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—SRC—urinary bladder cancer	7.17e-06	3.49e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—CDKN1A—urinary bladder cancer	7.16e-06	3.48e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—RHOA—urinary bladder cancer	7.16e-06	3.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PTEN—urinary bladder cancer	7.14e-06	3.47e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—FGFR3—urinary bladder cancer	7.12e-06	3.46e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—SRC—urinary bladder cancer	7.07e-06	3.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—EP300—urinary bladder cancer	7.07e-06	3.44e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—GPX1—urinary bladder cancer	7.06e-06	3.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—TNF—urinary bladder cancer	7.05e-06	3.43e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—EGFR—urinary bladder cancer	7.02e-06	3.42e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CREBBP—urinary bladder cancer	7e-06	3.41e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—KRAS—urinary bladder cancer	7e-06	3.4e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—ERCC2—urinary bladder cancer	6.93e-06	3.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IGF1—urinary bladder cancer	6.92e-06	3.36e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—EGFR—urinary bladder cancer	6.88e-06	3.35e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—SRC—urinary bladder cancer	6.88e-06	3.35e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—RHOA—urinary bladder cancer	6.88e-06	3.35e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—KRAS—urinary bladder cancer	6.86e-06	3.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—CDKN1A—urinary bladder cancer	6.86e-06	3.34e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—S100B—urinary bladder cancer	6.85e-06	3.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PTEN—urinary bladder cancer	6.85e-06	3.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—EP300—urinary bladder cancer	6.81e-06	3.31e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—PPARG—urinary bladder cancer	6.79e-06	3.3e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—TYMP—urinary bladder cancer	6.75e-06	3.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CREBBP—urinary bladder cancer	6.71e-06	3.27e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—TNF—urinary bladder cancer	6.69e-06	3.25e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—KRAS—urinary bladder cancer	6.63e-06	3.23e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IGF1—urinary bladder cancer	6.63e-06	3.23e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—SRC—urinary bladder cancer	6.62e-06	3.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.62e-06	3.22e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—EGFR—urinary bladder cancer	6.6e-06	3.21e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PTGS2—urinary bladder cancer	6.58e-06	3.2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CREBBP—urinary bladder cancer	6.56e-06	3.19e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—EGFR—urinary bladder cancer	6.54e-06	3.18e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—EP300—urinary bladder cancer	6.53e-06	3.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—CREBBP—urinary bladder cancer	6.53e-06	3.17e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CDH1—urinary bladder cancer	6.51e-06	3.17e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—MTHFR—urinary bladder cancer	6.51e-06	3.17e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—KRAS—urinary bladder cancer	6.51e-06	3.17e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—KRAS—urinary bladder cancer	6.5e-06	3.16e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—RHOA—urinary bladder cancer	6.5e-06	3.16e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.48e-06	3.15e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—ERBB2—urinary bladder cancer	6.37e-06	3.1e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—SRC—urinary bladder cancer	6.35e-06	3.09e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—RHOA—urinary bladder cancer	6.34e-06	3.08e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—EGFR—urinary bladder cancer	6.29e-06	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.28e-06	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—EGFR—urinary bladder cancer	6.28e-06	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—KRAS—urinary bladder cancer	6.23e-06	3.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CREBBP—urinary bladder cancer	6.22e-06	3.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—EGFR—urinary bladder cancer	6.2e-06	3.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—KRAS—urinary bladder cancer	6.18e-06	3.01e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CDH1—urinary bladder cancer	6.18e-06	3e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.17e-06	3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NCOR1—urinary bladder cancer	6.16e-06	3e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.12e-06	2.98e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NAT2—urinary bladder cancer	6.1e-06	2.97e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TP53—urinary bladder cancer	6.1e-06	2.97e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—RHOA—urinary bladder cancer	6.07e-06	2.96e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CREBBP—urinary bladder cancer	6.06e-06	2.95e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PPARG—urinary bladder cancer	6.04e-06	2.94e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CXCL8—urinary bladder cancer	6.04e-06	2.94e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—EGFR—urinary bladder cancer	6.03e-06	2.93e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PTGS2—urinary bladder cancer	6.01e-06	2.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—IL2—urinary bladder cancer	6e-06	2.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—HRAS—urinary bladder cancer	5.95e-06	2.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—KRAS—urinary bladder cancer	5.94e-06	2.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MYC—urinary bladder cancer	5.94e-06	2.89e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—KRAS—urinary bladder cancer	5.93e-06	2.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—ERBB2—urinary bladder cancer	5.86e-06	2.85e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—KRAS—urinary bladder cancer	5.86e-06	2.85e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—HRAS—urinary bladder cancer	5.83e-06	2.84e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—CREBBP—urinary bladder cancer	5.81e-06	2.82e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—EGFR—urinary bladder cancer	5.81e-06	2.82e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—urinary bladder cancer	5.78e-06	2.81e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL2—urinary bladder cancer	5.77e-06	2.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PTEN—urinary bladder cancer	5.73e-06	2.79e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CXCL8—urinary bladder cancer	5.7e-06	2.78e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—KRAS—urinary bladder cancer	5.69e-06	2.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MYC—urinary bladder cancer	5.69e-06	2.77e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—HRAS—urinary bladder cancer	5.64e-06	2.74e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CCND1—urinary bladder cancer	5.62e-06	2.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—ERBB2—urinary bladder cancer	5.62e-06	2.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—EGFR—urinary bladder cancer	5.57e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CXCL8—urinary bladder cancer	5.56e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—HRAS—urinary bladder cancer	5.53e-06	2.69e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—HRAS—urinary bladder cancer	5.53e-06	2.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ERBB2—urinary bladder cancer	5.5e-06	2.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—KRAS—urinary bladder cancer	5.48e-06	2.67e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—RHOA—urinary bladder cancer	5.48e-06	2.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—EP300—urinary bladder cancer	5.47e-06	2.66e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MMP9—urinary bladder cancer	5.46e-06	2.66e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL2—urinary bladder cancer	5.45e-06	2.65e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.44e-06	2.65e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.44e-06	2.65e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TERT—urinary bladder cancer	5.43e-06	2.64e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PTEN—urinary bladder cancer	5.43e-06	2.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CXCL8—urinary bladder cancer	5.33e-06	2.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL2—urinary bladder cancer	5.32e-06	2.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—HRAS—urinary bladder cancer	5.3e-06	2.58e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PPARG—urinary bladder cancer	5.28e-06	2.57e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—RRM2—urinary bladder cancer	5.27e-06	2.56e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—KRAS—urinary bladder cancer	5.26e-06	2.56e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HRAS—urinary bladder cancer	5.25e-06	2.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PTEN—urinary bladder cancer	5.24e-06	2.55e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ERBB2—urinary bladder cancer	5.21e-06	2.53e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCND1—urinary bladder cancer	5.18e-06	2.52e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EP300—urinary bladder cancer	5.18e-06	2.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL2—urinary bladder cancer	5.1e-06	2.48e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—CREBBP—urinary bladder cancer	5.07e-06	2.47e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ERBB2—urinary bladder cancer	5.07e-06	2.47e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HRAS—urinary bladder cancer	5.05e-06	2.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HRAS—urinary bladder cancer	5.04e-06	2.45e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—SRC—urinary bladder cancer	5.03e-06	2.45e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MMP9—urinary bladder cancer	5.03e-06	2.45e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.01e-06	2.44e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—EP300—urinary bladder cancer	5e-06	2.43e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PTEN—urinary bladder cancer	5e-06	2.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—FGFR3—urinary bladder cancer	4.98e-06	2.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL2—urinary bladder cancer	4.98e-06	2.42e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HRAS—urinary bladder cancer	4.98e-06	2.42e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCND1—urinary bladder cancer	4.97e-06	2.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTGS2—urinary bladder cancer	4.96e-06	2.41e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.88e-06	2.37e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.88e-06	2.37e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ESR1—urinary bladder cancer	4.84e-06	2.36e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HRAS—urinary bladder cancer	4.84e-06	2.35e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MMP9—urinary bladder cancer	4.82e-06	2.35e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.81e-06	2.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PTEN—urinary bladder cancer	4.79e-06	2.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EP300—urinary bladder cancer	4.77e-06	2.32e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTGS2—urinary bladder cancer	4.75e-06	2.31e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GSTT1—urinary bladder cancer	4.73e-06	2.3e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL2—urinary bladder cancer	4.72e-06	2.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CDKN1A—urinary bladder cancer	4.7e-06	2.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PTEN—urinary bladder cancer	4.69e-06	2.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HRAS—urinary bladder cancer	4.66e-06	2.27e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—SRC—urinary bladder cancer	4.64e-06	2.26e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EP300—urinary bladder cancer	4.57e-06	2.22e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MYC—urinary bladder cancer	4.51e-06	2.19e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EP300—urinary bladder cancer	4.47e-06	2.17e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HRAS—urinary bladder cancer	4.47e-06	2.17e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CDKN1A—urinary bladder cancer	4.45e-06	2.17e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—SRC—urinary bladder cancer	4.45e-06	2.16e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PTEN—urinary bladder cancer	4.44e-06	2.16e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.43e-06	2.16e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EGFR—urinary bladder cancer	4.41e-06	2.15e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—SRC—urinary bladder cancer	4.35e-06	2.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CDKN1A—urinary bladder cancer	4.34e-06	2.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTEN—urinary bladder cancer	4.33e-06	2.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CREBBP—urinary bladder cancer	4.24e-06	2.06e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EP300—urinary bladder cancer	4.24e-06	2.06e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IGF1—urinary bladder cancer	4.19e-06	2.04e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—EGFR—urinary bladder cancer	4.17e-06	2.03e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KRAS—urinary bladder cancer	4.17e-06	2.03e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MYC—urinary bladder cancer	4.16e-06	2.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTGS2—urinary bladder cancer	4.16e-06	2.02e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTEN—urinary bladder cancer	4.15e-06	2.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EP300—urinary bladder cancer	4.13e-06	2.01e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—SRC—urinary bladder cancer	4.12e-06	2e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EGFR—urinary bladder cancer	4.07e-06	1.98e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—SRC—urinary bladder cancer	4.01e-06	1.95e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MYC—urinary bladder cancer	3.98e-06	1.94e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—EP300—urinary bladder cancer	3.95e-06	1.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—KRAS—urinary bladder cancer	3.94e-06	1.92e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.93e-06	1.91e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EGFR—urinary bladder cancer	3.9e-06	1.9e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MYC—urinary bladder cancer	3.87e-06	1.88e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KRAS—urinary bladder cancer	3.84e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—RHOA—urinary bladder cancer	3.84e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EGFR—urinary bladder cancer	3.81e-06	1.85e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—urinary bladder cancer	3.7e-06	1.8e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KRAS—urinary bladder cancer	3.68e-06	1.79e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTEN—urinary bladder cancer	3.62e-06	1.76e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EGFR—urinary bladder cancer	3.61e-06	1.76e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KRAS—urinary bladder cancer	3.6e-06	1.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MYC—urinary bladder cancer	3.6e-06	1.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ERBB2—urinary bladder cancer	3.55e-06	1.73e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—HRAS—urinary bladder cancer	3.54e-06	1.72e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EGFR—urinary bladder cancer	3.52e-06	1.71e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—EP300—urinary bladder cancer	3.46e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—urinary bladder cancer	3.41e-06	1.66e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KRAS—urinary bladder cancer	3.41e-06	1.66e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCL8—urinary bladder cancer	3.37e-06	1.64e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—HRAS—urinary bladder cancer	3.35e-06	1.63e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KRAS—urinary bladder cancer	3.32e-06	1.62e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.28e-06	1.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—urinary bladder cancer	3.27e-06	1.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—HRAS—urinary bladder cancer	3.26e-06	1.59e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL2—urinary bladder cancer	3.22e-06	1.57e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCND1—urinary bladder cancer	3.14e-06	1.53e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—HRAS—urinary bladder cancer	3.13e-06	1.52e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HRAS—urinary bladder cancer	3.06e-06	1.49e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—TYMS—urinary bladder cancer	3.05e-06	1.48e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MMP9—urinary bladder cancer	3.05e-06	1.48e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CDKN1A—urinary bladder cancer	3.04e-06	1.48e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTEN—urinary bladder cancer	3.03e-06	1.47e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GSTM1—urinary bladder cancer	3.01e-06	1.47e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NCOR1—urinary bladder cancer	3.01e-06	1.47e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HRAS—urinary bladder cancer	2.9e-06	1.41e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EP300—urinary bladder cancer	2.89e-06	1.41e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.89e-06	1.4e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.83e-06	1.38e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HRAS—urinary bladder cancer	2.82e-06	1.37e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SRC—urinary bladder cancer	2.81e-06	1.37e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.66e-06	1.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MYC—urinary bladder cancer	2.52e-06	1.23e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EGFR—urinary bladder cancer	2.46e-06	1.2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KRAS—urinary bladder cancer	2.33e-06	1.13e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.16e-06	1.05e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.07e-06	1.01e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—urinary bladder cancer	2.07e-06	1.01e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—HRAS—urinary bladder cancer	1.98e-06	9.62e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.7e-06	8.27e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.48e-06	7.21e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—EP300—urinary bladder cancer	1.41e-06	6.87e-06	CbGpPWpGaD
